FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC (FORTIFI-HN01)
A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β).
This study intends to evaluate the safety and efficacy of ficerafusp alfa in combination with pembrolizumab versus placebo with pembrolizumab in 1L PD-L1-positive, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The mechanism of action of ficerafusp alfa involves dual targeting of two cancer targets, EGFR and TGF-β, which are known to drive solid tumor growth and metastasis.
Phase 2 of the study will identify an optimal biologic dose (OBD) supported by the safety, tolerability, PK, PD, and efficacy data of ficerafusp alfa. In this part, eligible subjects will be randomized to one of three treatment arms at a 1:1:1 ratio:
- Arm A: ficerafusp alfa 1500 mg once weekly (QW) + pembrolizumab 200 mg every three weeks (Q3W).
- Arm B: ficerafusp alfa 750 mg QW + pembrolizumab 200 mg Q3W.
- Arm C (control): placebo QW + pembrolizumab 200 mg Q3W.
The primary objective for the phase 3 portion is to compare the efficacy in subjects treated with ficerafusp alfa at the selected OBD in combination with pembrolizumab versus placebo with pembrolizumab. Eligible subjects will be randomized 2:1 in the treatment versus control arm during the phase 3 portion.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: Medical Affairs
- Phone Number: 1-617-468-4219
- Email: FORTIFI_inquiries@bicara.com
Study Locations
-
-
-
Buenos Aires, Argentina, C1190
- Recruiting
- CEMIC (Site # 2301)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Buenos Aires, Argentina, C1425
- Recruiting
- ICM Center (Site # 2306)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pilar, Argentina, B1629ODT
- Recruiting
- Hospital Universitario Austral (Site # 2303)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rosario, Argentina, CP2000
- Recruiting
- Sanatorio de la Mujer (Site # 2305)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Santa Fe, Argentina, S2002KDT
- Recruiting
- Hospital Provincial del Centenario (Site # 2302)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
New South Wales
-
Camperdown, New South Wales, Australia, 2050
- Recruiting
- Chris O'Brien Lifehouse (Site#0302)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Kingswood, New South Wales, Australia, 2747
- Recruiting
- Nepean Hospital (Site #0306)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Waratah, New South Wales, Australia, 2298
- Recruiting
- Calvary Mater Newcastle (Site#0304)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Queensland
-
Southport, Queensland, Australia, 4215
- Recruiting
- Gold Coast University Hospital (Site #0305)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Tugun, Queensland, Australia, 4224
- Recruiting
- John Flynn Private Hospital (Site#0307)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Victoria
-
Heidelberg, Victoria, Australia, 3084
- Recruiting
- Austin Health (Site #0303)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
North Melbourne, Victoria, Australia, 3051
- Recruiting
- Peter Macallum Cancer Centre (Site#0301)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Western Australia
-
Murdoch, Western Australia, Australia, 6150
- Recruiting
- Fiona Stanley Hospital (Site#0308)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Salzburg, Austria, 5020
- Recruiting
- Hematology and Medical Oncology, Paracelsus Medical University (Site #1602)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Vienna, Austria, 1090
- Recruiting
- Medical University Vienna (Site #1601)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Bruges, Belgium, 8000
- Recruiting
- AZ St-Jan Brugge Oostende av (Campus Sint-Jan) (Site #1007)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Mons, Belgium, 7000
- Recruiting
- CHU Ambroise Paré (Site #1005)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Namur, Belgium, 5000
- Recruiting
- CHU UCL Namur, Site Ste. Elisabeth (Site #1002)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Namur, Belgium, 5530
- Recruiting
- CHU UCL Namur, Site Mont-Godinne (Site #1003)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Sint-Niklaas, Belgium, 9100
- Recruiting
- Vitaz (Site #1001)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Wilrijk, Belgium, 2610
- Recruiting
- ZAS Augustinus (Site #1006)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Barretos, Brazil, 14784-400
- Recruiting
- Hospital de Amor de Barretos - Fundação Pio XII (Site # 2413)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Belém, Brazil, 66063495
- Recruiting
- Centro de Tratamento Oncologico (Site # 2421)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Curitiba, Brazil, 80810-050
- Recruiting
- CIONC-Centro Integrado de Oncologia de Curitiba (Site # 2404)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Fortaleza, Brazil, 60430235
- Recruiting
- Hospital Haroldo Juaçaba - Instituto do Câncer do Ceará (Site # 2414)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Ijuí, Brazil, 98700-000
- Recruiting
- Oncosite - Centro de Pesquisa Clinica e Oncologia (Site # 2402)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Jaú, Brazil, 17210-120
- Recruiting
- Fundação Doutor Amaral Carvalho (Site # 2411)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Natal, Brazil, 59062-000
- Recruiting
- Liga Norte-Rio-Grandense Contra o Câncer (Site # 2422)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Passo Fundo, Brazil, 99010-260
- Recruiting
- Hospital de Clínicas de Passo Fundo (Site # 2419)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Porto Alegre, Brazil, 91350-200
- Recruiting
- Hospital Nossa Senhora da Conceicao (Site # 2403)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rio de Janeiro, Brazil, 22250-905
- Recruiting
- Grupo Oncoclínicas (Site # 2412)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Santa Cruz do Sul, Brazil, 96835-100
- Recruiting
- Hospital Ana Nery (Site # 2415)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Santa Lúcia, Brazil, 30360680
- Recruiting
- Oncoclinicas do Brasil Serviços Médicos S.A - Oncocentro BH (Site # 2401)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Caetano do Sul, Brazil, 09541-270
- Recruiting
- Centro de Oncologia do ABC - Unidade Santo Andre (Site # 2410)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São José do Rio Preto, Brazil, 15090-000
- Recruiting
- Centro Integrado de Pesquisa do Hospital de Base de São José do Rio Preto/FUNFAR (Site # 2406)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Paulo, Brazil, 01246-000
- Recruiting
- Instituto do Cancer do Estado de Sao Paulo (ICESP) (Site # 2417)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Paulo, Brazil, 01509-900
- Recruiting
- A. C. Camargo Cancer Center (Site # 2409)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Paulo, Brazil, 04014-002
- Recruiting
- IBCC Núcleo de Pesquisa e Ensino (Site # 2405)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Paulo, Brazil, 04543
- Recruiting
- Oncoclínicas - SP (Site # 2416)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
São Paulo, Brazil, 08270-120
- Recruiting
- Hospital Santa Marcelina (Site # 2418)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Vitoria ES
-
Santa Cecília, Vitoria ES, Brazil, 29043-260
- Recruiting
- AFECC Hospital Santa Rita de Cassia (Site # 2420)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Toronto, Canada, M4N 3M5
- Recruiting
- Sunnybrook Health Sciences Centre (Site # 0204)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 4E6
- Recruiting
- BC Cancer - Vancouver (Site #0202)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 0C1
- Recruiting
- Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopital Notre-Dame (Site #0203)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Hradec Králové, Czechia, 500 03
- Recruiting
- Fakultni Nemocnice Hradec Kralove (FNHK) (Site # 2101)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Prague, Czechia, 15006
- Recruiting
- Fakultni nemocnice Motol a Homolka (Site #2102)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Amiens, France, 80480
- Recruiting
- CHU Amiens - Hopital Sud (Site #0809)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Bordeaux, France, 33075
- Recruiting
- CHU de Bordeaux (Site # 0812)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Lille, France, 59000
- Recruiting
- Centre Oscar Lambret (Site # 0804)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Lyon, France, 69004
- Recruiting
- Centre Hospitalier de la Croix Rousse (Site #0810)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Paris, France, 75005
- Recruiting
- Institut Curie - site de Paris (Site # 0813)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rennes, France, 35042
- Recruiting
- CRLCC Eugene Marquis (Site #0805)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Saint-Grégoire, France, 35760
- Recruiting
- Les Hopitaux Prives Rennais - Saint-Gregoire (Site #0807)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Strasbourg, France, 67200
- Recruiting
- Centre Regional Lutte Contre Le Cancer - PAUL STRAUSS (Site #0808)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Toulouse, France, 31059
- Recruiting
- IUCT-Oncopole (Site # 0811)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Vandœuvre-lès-Nancy, France, 54519
- Recruiting
- ICL - Alexis Vautrin (Site #0806)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Villejuif, France, 94805
- Recruiting
- Institut Gustave Roussy (Site #0801)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Aachen, Germany, 52074
- Recruiting
- Universitaetsklinikum Aachen AOeR (Site #0710)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Berlin, Germany, 12200
- Recruiting
- Charite - Campus Benjamin Franklin (Site # 0701)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Berlin, Germany, 12351
- Recruiting
- Vivantes Klinikum Neukoelln (Site # 0714)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Braunschweig, Germany, 38114
- Recruiting
- Staedtisches Klinikum Braunschweig gGmbH (Site # 0709)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Chemnitz, Germany, 09116
- Recruiting
- Klinikum Chemnitz gGmbH (Site # 0705)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Dresden, Germany, 01067
- Recruiting
- Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt (Site #0707)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Dresden, Germany, 01307
- Recruiting
- Universitaetsklinikum Carl Gustav Carus TU Dresden (Site # 0711)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Düsseldorf, Germany, 40225
- Recruiting
- Heinrich-Heine-Universitaet Duesseldorf (Site #0706)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Essen, Germany, 45147
- Recruiting
- Universitaetsklinikum Essen (Site # 0716)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Göttingen, Germany, 37075
- Recruiting
- Universitaetsmedizin Goettingen (Site # 0708)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Hanover, Germany, 30625
- Recruiting
- Medizinische Hochschule Hannover (Site # 0718)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Karlsruhe, Germany, 76137
- Recruiting
- Vincentius-Diakonissen-Kliniken gAG/St. Vincentius-Kliniken (Site #0717)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
München, Germany, 81675
- Recruiting
- Technische Universität München School of Medicine (Site # 0715)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Stuttgart, Germany, 70174
- Recruiting
- Klinikum Stuttgart-Katharinenhospital (Site # 0703)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Ulm, Germany, 89075
- Recruiting
- Universitaetsklinikum Ulm (Site # 0702)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Athens, Greece, 12461
- Recruiting
- U.G.H. ATTIKON - General Hospital of West Attica "H AGIA VARVARA" (Site # 1701)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Larissa, Greece, 41110
- Recruiting
- University General Hospital of Larissa (Site # 1702)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Madurai, India, 625107
- Recruiting
- Meenakshi Mission Hospital & Research Centre (Site # 3003)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Sūrat, India, 395004
- Recruiting
- Nirmal Hospital (Site # 3002)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Cork, Ireland, T12 DC4A
- Recruiting
- Cork University Hospital - Consultants Private Clinic (Site # 0603)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Dublin, Ireland, D08 NHY1
- Recruiting
- Trinity College Dublin (TCD) - St. James's Hospital (SJH) (Site #0602)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Dublin, Ireland, D09 V2N0
- Recruiting
- Beaumont Hospital (Site #0601)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Beersheba, Israel, 84101
- Recruiting
- Soroka Medical Center (Site # 1901)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Jerusalem, Israel, 9112001
- Recruiting
- Hadassah Medical Center (Site # 1903)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Petah Tikva, Israel, 49100
- Recruiting
- Rabin Medical Center (Site # 1904)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Tel Aviv, Israel, 6423906
- Recruiting
- Sourasky Medical Center (Site # 1902)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Bologna, Italy, 40138
- Recruiting
- Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi (Site #0904)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Cagliari, Italy, 09121
- Recruiting
- ARNAS G. Brotzu (Site # 913)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Florence, Italy, 50134
- Recruiting
- Azienda Ospedaliera Universitaria Careggi (Site #0911)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Milan, Italy, 20132
- Recruiting
- Ospedale San Raffaele (Site #0907)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Milan, Italy, 20133
- Recruiting
- Fondazione IRCCS Istituto Nazionale dei Tumori (Site #0901)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Milan, Italy, 20142
- Recruiting
- ASST Santi Paolo e Carlo, Ospedale San Paolo Polo Universitario (Site #0905)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Milan, Italy, 20162
- Recruiting
- Azienda Socio Sanitaria Territoriale Niguarda (Site # 0912)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Naples, Italy, 80131
- Recruiting
- Istituto Nazionale Tumori Fondazione G. Pascale (Site #0915)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Naples, Italy, 80131
- Recruiting
- UOC Oncoematologia AOU - University Luigi Vanvitelli (Site # 0916)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Padova, Italy, 35128
- Recruiting
- IOV - Istituto Oncologico Veneto IRCCS (Site # 0910)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Palermo, Italy, 90127
- Recruiting
- Policlinico P. Giaccone di Palermo (Site #0908)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pavia, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo (Site # 0903)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pisa, Italy, 56126
- Recruiting
- Azienda Ospedaliero Universitaria Pisana (Site # 0909)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rome, Italy, 00161
- Recruiting
- Azienda Ospedaliero-Universitaria Policlinico Umberto I (Site #0917)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rome, Italy, 00168
- Recruiting
- Fondazione Policlinico Universitario - Agostino Gemelli (Site #0918)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rome, Italy, 00186
- Recruiting
- Fatebenefratelli Isola Tiberina, Gemelli Isola (Site #0906)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rozzano, Italy, 20089
- Recruiting
- Humanitas Mirasole S.p.A (Site # 0919)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Siena, Italy, 53100
- Recruiting
- A.O.U. Senese Policlinico Santa Maria alle Scotte (Site # 0902)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Kōtoku, Japan, 135-8550
- Recruiting
- Cancer Institute Hospital of JFCR (Site # 3107)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
George Town, Malaysia, 11200
- Recruiting
- Mount Miriam Cancer Hospital (Site # 2802)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Kuala Lumpur, Malaysia, 50586
- Recruiting
- Hospital Kuala Lumpur (Site # 2803)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Kuala Lumpur, Malaysia, 59100
- Recruiting
- University Malaya Medical centre (Site # 2805)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Kuching, Malaysia, 93200
- Recruiting
- Sarawak General Hospital (Site # 2801)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pulau Pinang, Malaysia, 10450
- Recruiting
- Hospital Pulau Pinang (Site # 2804)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Christchurch, New Zealand, 8011
- Recruiting
- Christchurch Hospital NZ (Site #0401)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rotorua, New Zealand, 3010
- Recruiting
- Rotorua Hospital (Site#0402)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Gdansk, Poland, 80-214
- Recruiting
- UNIWERSYTECKIE CENTRUM KLINICZNE (Site #1401)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Gliwice, Poland, 44-102
- Recruiting
- Centrum Onkologii-Instytut im.M.Sklodowskiej Curie (Site # 1405)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Katowice, Poland, 40-519
- Recruiting
- Pratia Onkologia Katowice (Site #1403)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Konin, Poland, 62-500
- Recruiting
- Przychodnia Lekarska Komed (Site #1407)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Krakow, Poland, 31-826
- Recruiting
- Szpital Specjalistyczny im. L.Rydygiera w Krakowie (Site #1404)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Siedlce, Poland, 08-110
- Recruiting
- Mazowiecki Szpital Wojewódzki im. sw. Jana Pawla II w Siedlcach Sp. z o.o. (Site #1402)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Warsaw, Poland, 02-781
- Recruiting
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curiee - Panstwowy Instytut (Site #1406)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Braga, Portugal, 4710-243
- Recruiting
- Centro Clínico Académico de Braga (Site #1506)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Coimbra, Portugal
- Recruiting
- Instituto Portugues de Oncologia de Coimbra Francisco Gentil, EPE (Site #1503)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Lisbon, Portugal, 1099-023
- Recruiting
- Instituto Português de Oncologia Lisboa (Site #1508)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Portimão, Portugal, 8500-338
- Recruiting
- Centro Hospitalar Algarve (Site #1501)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Porto, Portugal, 4200-072
- Recruiting
- Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE (Site #1505)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Porto, Portugal, 4200-319
- Recruiting
- Centro Hospitalar Universitario de Sao Joao (Site #1507)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Senhora da Hora, Portugal, 4464-509
- Recruiting
- Unidade Local de Saude de Matosinhos, E.P.E. - Hospital Pedro Hispano (Site #1502)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Vila Nova de Gaia, Portugal, 4434-502
- Recruiting
- Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E. (Site # 1504)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Novena, Singapore, 308433
- Recruiting
- Tan Tock Seng Hospital (Site # 2902)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Singapore, Singapore, 168583
- Recruiting
- National Cancer Centre Singapore (Site # 2901)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Busan, South Korea, 49267
- Recruiting
- Kosin University Gospel Hospital (Site # 2707)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Goyang-si, South Korea, 10408
- Recruiting
- National Cancer Center (Site # 2704)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Hwasun, South Korea, 58128
- Recruiting
- Chonnam National University Hwasun Hospital (Site # 2705)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seongnam, South Korea, 13620
- Recruiting
- Seoul National University Bundang Hospital (Site # 2706)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seoul, South Korea, 3080
- Recruiting
- Seoul National University Hospital (Site # 2701)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seoul, South Korea, 3722
- Recruiting
- SEVERANCE HOSPITAL, YONSEI UNIVERSITY (Site # 2702)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seoul, South Korea, 6351
- Recruiting
- Samsung Medical Center (Site # 2703)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Badalona, Spain, 8916
- Recruiting
- ICO Badalona - Hospital Universitari Germans Trias i Pujol (Site # 1311)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Barcelona, Spain, 08035
- Recruiting
- Hospital Universitari Vall d'Hebron (Site #1301)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Barcelona, Spain, 08036
- Recruiting
- Hospital Clinic de Barcelona (Site #1305)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Barcelona, Spain, 08041
- Recruiting
- Hospital de la Santa Creu I Sant Pau Site #1304
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Barcelona, Spain, 08908
- Recruiting
- Institut Catala d'Oncologia (Site # 1302)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Madrid, Spain, 28027
- Recruiting
- Clinica Universidad de Navarra- Madrid (Site #1310)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Madrid, Spain, 28041
- Recruiting
- Hospital Universitario 12 De Octubre (Site #1303)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pamplona, Spain, 31008
- Recruiting
- Clinica Universidad de Navarra (Site #1306)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Santander, Spain, 39008
- Recruiting
- Hospital Universitario Marques de Valdecilla (HUMV) (Site #1309)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Valencia, Spain, 46010
- Recruiting
- Hospital Clinico Universitario de Valencia (Site #1307)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Valencia, Spain, 46014
- Recruiting
- Hospital General Universitario de Valencia (Site #1308)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Fribourg, Switzerland, 1752
- Recruiting
- HFR Fribourg Kantonsspital Fribourg (Site # 1803)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Geneva, Switzerland, 1205
- Recruiting
- Hopitaux Universitaires de Geneve (Site # 1802)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Lausanne, Switzerland, 1011
- Recruiting
- Centre Hospitalier Universitaire Vaudois (CHUV) (Site # 1801)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Changhua, Taiwan, 50006
- Recruiting
- Changhua Christian Medical Foundation Changhua Christian Hospital (Site # 2602)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Kaohsiung City, Taiwan, 807
- Recruiting
- Kaohsiung Medical University Chung-Ho Memorial Hospital (Site # 2601)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-421
- Email: FORTIFI_inquiries@bicara.com
-
Taichung, Taiwan, 40447
- Recruiting
- China Medical University Hospital (CMUH) (Site # 2603)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Taipei, Taiwan, 10002
- Recruiting
- National Taiwan University Hospital (Site # 2604)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Bangkok, Thailand, 10400
- Recruiting
- Phramongkutklao Hospital (Site # 2505)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Bangkok, Thailand, 10400
- Recruiting
- Rajavithi Hospital (Site # 2504)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Chiang Mai, Thailand, 50200
- Recruiting
- Maharaj Nakorn Chiang Mai Hospital (Site # 2506)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Dusit, Thailand, 10300
- Recruiting
- Vajira Hospital (Site # 2503)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Hat Yai, Thailand, 90110
- Recruiting
- Songklanagarind Hospital (Site # 2502)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Ankara, Turkey (Türkiye), 6100
- Recruiting
- Hacettepe University Medical Faculty (Site # 1201)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Ankara, Turkey (Türkiye), 6520
- Recruiting
- Memorial Ankara Hospital (Site # 1202)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Antalya, Turkey (Türkiye), 7020
- Recruiting
- Memorial Antalya Hastanesi (Site # 1204)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Istanbul, Turkey (Türkiye), 34098
- Recruiting
- Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty (Site # 1203)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Izmir, Turkey (Türkiye), 35330
- Recruiting
- Dokuz Eylul University Medical School (Site # 1206)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
-
Aberdeen, United Kingdom, AB25 2ZN
- Recruiting
- Aberdeen Royal Infirmary (Site #0504)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Birmingham, United Kingdom, B15 2TH
- Recruiting
- University Hospitals Birmingham (Queen Elizabeth Hospital) (Site #0512)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Cambridge, United Kingdom, CB2 0QQ
- Recruiting
- Cambridge University Hospitals (Site #0513)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Glasgow, United Kingdom, G12 0YN
- Recruiting
- Beatson West of Scotland Cancer Centre (Site # 0510)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Leeds, United Kingdom, LS9 7TF
- Recruiting
- St James University Hospital Leeds (Site #0511)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Liverpool, United Kingdom, L7 8YA
- Recruiting
- Clatterbridge Cancer Center NHS Foundation (Site #0507)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
London, United Kingdom, SW3 6JJ
- Recruiting
- Royal Marsden Hospital - Chelsea (Site #0505)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
London, United Kingdom, WC1E 6AG
- Recruiting
- University College London Hospital (Site #0502)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Manchester, United Kingdom, M20 4BX
- Recruiting
- The Christie Hospital (Site #0508)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Middlesex, United Kingdom, HA6 2RN
- Recruiting
- Mount Vernon Cancer Centre (Site #0506)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Newcastle upon Tyne, United Kingdom, NE7 7DN
- Recruiting
- Newcastle University (Site # 509)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Nottingham, United Kingdom, NG5 1PB
- Recruiting
- Nottingham University Hospitals City Campus (Site #0503)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Oxford, United Kingdom, OX3 7LE
- Recruiting
- Churchill Hospital (Site #0515)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Portsmouth, United Kingdom, PO6 3LY
- Recruiting
- Queen Alexandra Hospital (Site # 0514)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Sutton, United Kingdom, SM2 5PT
- Recruiting
- Royal Marsden Hospital- London (Site # 0501)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Recruiting
- University of Alabama Hospital (Site # 0137)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Arizona
-
Phoenix, Arizona, United States, 85054
- Recruiting
- Mayo Clinic Hospital (Site #0147)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
California
-
La Jolla, California, United States, 92093
- Recruiting
- UC San Diego Moores Cancer Center (Site #0107)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Los Angeles, California, United States, 90095
- Recruiting
- UCLA Department of Medicine - Hematology/Oncology (Site #0106)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Sacramento, California, United States, 95817
- Recruiting
- UC Davis (Site#0144)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
San Francisco, California, United States, 94143
- Recruiting
- University of California San Francisco (Site #0130)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Stanford, California, United States, 94305
- Recruiting
- Stanford Cancer Institute (Site #0150)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Recruiting
- Rocky Mountain Cancer Centers, LLP (Site #0122)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Aurora, Colorado, United States, 80045
- Recruiting
- Rocky Mountain Regional VAMC (Site #0124)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of Colorado Cancer Center (UCCC) - Anschutz Medical Campus (Site#0121)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Recruiting
- ChristianaCare Helen F. Graham Cancer Center and Research Institute (Site # 127)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Recruiting
- Mayo Clinic Florida (Site #0148)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Palm Bay, Florida, United States, 32901
- Recruiting
- Cancer Care Centers of Brevard (Site #0136)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Tampa, Florida, United States, 33612
- Recruiting
- Moffit Cancer Center (Site #0105)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Illinois
-
Chicago, Illinois, United States, 60064
- Recruiting
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- Recruiting
- University of Iowa Hospitals & Clinics (Site#0140)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Kansas
-
Westwood, Kansas, United States, 66205
- Recruiting
- University of Kansas Medical Center Research Institute, Inc. (Site #0149)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- Recruiting
- University of Kentucky, Markey Cancer Center (Site # 109)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Louisville, Kentucky, United States, 40202
- Recruiting
- Norton Cancer Institute (Site#0111)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Louisville, Kentucky, United States, 40202
- Recruiting
- The University of Louisville, James Graham Brown Cancer Center (Site#0115)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Recruiting
- University of Maryland Medical Group (Site #0112)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Recruiting
- Massachusetts General Hospital (Site #0131)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Boston, Massachusetts, United States, 02136
- Recruiting
- Dana-Farber Cancer Institute (Site#0101)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan (Site # 161)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Minnesota
-
Maplewood, Minnesota, United States, 55109
- Recruiting
- Site #0156
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic Cancer Center - Rochester (Site #0146)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine (Site #0114)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Recruiting
- Hackensack Meridian Health (Site # 119)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Newark, New Jersey, United States, 07103
- Recruiting
- Rutgers- Cancer Institute (Site #0145)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
New York
-
New York, New York, United States, 10003
- Recruiting
- Mount Sinai (Site #0155)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
New York, New York, United States, 10021
- Recruiting
- Memorial Sloan Kettering Cancer Center (Site#0142)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
North Carolina
-
Durham, North Carolina, United States, 27703
- Recruiting
- Duke University Health System (Site#0118)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Ohio
-
Canton, Ohio, United States, 44708
- Recruiting
- Mercy Hospital (Site#0154)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Cincinnati, Ohio, United States, 45221
- Recruiting
- University of Cincinnati Cancer Institute (Site#0117)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Cleveland, Ohio, United States, 44106
- Recruiting
- University Hospitals Seidman Cancer Center (Site #0151)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic (Site #0108)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Oregon
-
Portland, Oregon, United States, 97213
- Recruiting
- Providence Portland Medical Center (Site #0113)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15206
- Recruiting
- UPMC Hillman Cancer Center (Site #0103)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Pittsburgh, Pennsylvania, United States, 15240
- Recruiting
- VA Pittsburgh Healthcare System (Site #0123)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Recruiting
- Lifespan Cancer Institute (Site #0132)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina (MUSC) (Site#0104)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Tennessee
-
Nashville, Tennessee, United States, 37203
- Recruiting
- SCRI-Oncology Partners (Site#0126)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Nashville, Tennessee, United States, 37232
- Recruiting
- Vanderbilt-Ingram Cancer Center (Site #0116)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Texas
-
Houston, Texas, United States, 77005
- Recruiting
- MD Anderson Cancer Center (Site#0102)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Waco, Texas, United States, 676712
- Recruiting
- SCRI- Texas Oncology- Central South (Site #0152)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Virginia
-
Charlottesville, Virginia, United States, 22904
- Recruiting
- University of Virginia (Site#0134)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Richmond, Virginia, United States, 23219
- Recruiting
- Virginia Commonwealth University (VCU) Massey Cancer Center (Site #0129)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Richmond, Virginia, United States, 23249
- Recruiting
- Richmond Department of Veterans Affairs (Site #0138)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Washington
-
Edmonds, Washington, United States, 98026
- Recruiting
- Swedish Cancer Institute - North Campus Edmonds (Site # 0160)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seattle, Washington, United States, 98104
- Recruiting
- Swedish Cancer Institute (Site # 0159)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Seattle, Washington, United States, 98109
- Recruiting
- University of Washington - Seattle Cancer Care Alliance (Site #0125)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Vancouver, Washington, United States, 98684
- Recruiting
- Northwest Cancer Specialists, PC (Site#0120)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- Recruiting
- William S. Middleton Memorial Veteran's Hospital (Site #0141)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Madison, Wisconsin, United States, 53792
- Recruiting
- University of Wisconsin Hospital and Clinics (Site #0157)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
Milwaukee, Wisconsin, United States, 53233
- Recruiting
- Advocate Aurora Research Institute (Site # 0153)
-
Contact:
- Principal Investigator
- Phone Number: 617-468-4219
- Email: FORTIFI_inquiries@bicara.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥18 years on the day the Informed Consent Form is signed.
- Histologically or cytologically confirmed R or M HNSCC. Eligible primary tumor locations are oral cavity, hypopharynx, larynx or oropharynx (with documented HPV-negative disease if presenting with OPSCC). Note: primary tumor location of paranasal sinuses and nasopharynx, any histology are excluded.
- No prior systemic therapy administered in the R or M setting; and completed systemic therapy >6 months prior if given as part of multimodal treatment for locoregionally advanced disease in the adjuvant or definitive setting.
- Archival tumor tissue or willing to undergo pretreatment biopsy at Screening if archival tissue is insufficient or unavailable.
- PD-L1 CPS ≥1.
- Measurable disease based on RECIST 1.1.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- Adequate organ function, as defined in the protocol.
Exclusion Criteria:
- Disease suitable for local therapy administered with curative intent.
- Prior treatment with anti-TGFβ therapy.
- Prior therapy with an anti-EGFR antibody (exception: radio sensitizing agents and multimodal treatment for locoregionally advanced disease).
- Prior history of Grade ≥2 intolerance or hypersensitivity reaction to anti-EGFR therapy or other murine proteins.
- Prior therapy with an immune checkpoint inhibitor completed within 6 months prior to study treatment initiation.
- Progressive disease <6 months from completion of curative intent systemic therapy for locoregionally advanced HNSCC.
- Life expectancy less than 3 months.
- Known active central nervous system metastases, history of spinal cord compression from tumor involvement, a history of carcinomatous meningitis, or leptomeningeal disease are excluded.
- Current active major bleeding, or a recent major bleeding episode within 4 weeks prior to enrollment.
- Subject participated in another clinical study or received treatment with another investigational drug must wait at least 5 half-lives of the treatment received or 4 weeks (whichever is shorter) following prior therapy.
- Active autoimmune disease requiring systemic treatment in the past 2 years.
- Subjects with chronic hepatitis B virus (HBV) infection with active disease who meet the criteria for anti-HBV therapy and are not on a suppressive antiviral therapy prior to initiation of study treatment.
- Subjects with a known history of hepatitis C virus (HCV) who have not completed curative antiviral treatment or have an HCV viral load above the limit of quantification at Screening.
- Known history of human immunodeficiency virus (HIV).
- Receipt of any organ transplantation, including autologous and allogeneic stem cell transplantation, with the exception of transplants that do not require immunosuppression.
- Known to be diagnosed and/or treated for any other additional malignancy within 2 years prior to randomization with the exception of the following: curatively treated basal cell carcinoma or squamous cell carcinoma of the skin, and curatively resected in situ cervical cancer, and curatively resected in situ breast cancer, and low-risk early stage prostate cancer.
- Any condition requiring systemic treatment with either corticosteroids (>10 mg daily of prednisone or equivalent) or other immunosuppressive medication within 7 days prior to the first dose of study treatment, except for topical, intranasal, intrabronchial, or ocular steroids.
- Use of a live or live attenuated vaccine within 4 weeks prior to Screening.
Other Inclusion/Exclusion criteria may apply as defined in the protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Phase 2 Arm A
ficerafusp alfa 1500 mg QW + pembrolizumab 200 mg every 3 weeks (Q3W) |
Investigational Immunotherapy agent used in combination with investigational agent |
|
Experimental: Phase 2 Arm B
ficerafusp alfa 750 mg QW + pembrolizumab 200 mg Q3W |
Investigational Immunotherapy agent used in combination with investigational agent |
|
Placebo Comparator: Phase 2 Arm C
placebo QW + pembrolizumab 200 mg Q3W |
Immunotherapy agent used in combination with investigational agent Placebo Control |
|
Experimental: Phase 3 OBD Arm
ficerafusp alfa OBD + pembrolizumab 200 mg Q3W |
Investigational Immunotherapy agent used in combination with investigational agent |
|
Placebo Comparator: Phase 3 Arm C
placebo QW + pembrolizumab 200 mg Q3W |
Immunotherapy agent used in combination with investigational agent Placebo Control |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Phase 2 - Incidence and severity of TEAEs, treatment-treatment emergent SAEs TEAEs leading to dose interruption, dose reduction, or permanent discontinuation.
Time Frame: Up to 30 days post end of treatment for TEAEs (90 days for SAEs).
|
To assess safety and tolerability of ficerafusp alfa with pembrolizumab. |
Up to 30 days post end of treatment for TEAEs (90 days for SAEs).
|
|
Phase 2 - Objective Response Rate (ORR) per RECIST 1.1 by blinded independent central review (BICR)
Time Frame: Approximately 1 year.
|
ORR is defined as the proportion of subjects in the DDS who have a confirmed CR or PR per RECIST 1.1. by BICR. |
Approximately 1 year.
|
|
Phase 3 - Objective Response Rate (ORR) per RECIST 1.1 by BICR.
Time Frame: Approximately 2 years.
|
ORR is defined as the proportion of subjects in the DDS who have a confirmed CR or PR per RECIST 1.1. by BICR. |
Approximately 2 years.
|
|
Phase 3 - Overall Survival (OS)
Time Frame: Approximately 3 years.
|
OS: Defined as the time from the randomization to death due to any cause. |
Approximately 3 years.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Phase 2 - Duration of Response (DOR) per RECIST 1.1 by BICR.
Time Frame: Approximately 1 year.
|
DOR: For subjects who demonstrated CR or PR, DOR is defined as the time from first documented evidence of CR or PR until disease progression or death, whichever occurs first, per RECIST 1.1 by BICR. |
Approximately 1 year.
|
|
Phase 3 - Incidence and severity of TEAEs, treatment-treatment emergent SAEs TEAEs leading to dose interruption, dose reduction, or permanent discontinuation.
Time Frame: Up to 30 days post end of treatment for TEAEs (90 days for SAEs).
|
To assess safety and tolerability of ficerafusp alfa with pembrolizumab. |
Up to 30 days post end of treatment for TEAEs (90 days for SAEs).
|
|
Phase 3 - Progression-free survival (PFS) per RECIST 1.1 by BICR.
Time Frame: Approximately 3 years.
|
PFS: Defined as the time from randomization to the first documented PD per RECIST 1.1 as determined by BICR or death due to any cause, whichever occurs first. |
Approximately 3 years.
|
|
Phase 3 - Objective Response Rate (ORR) per RECIST 1.1 by BICR.
Time Frame: Approximately 3 years.
|
ORR: Defined as confirmed CR + PR per RECIST 1.1 by BICR. (FAS). |
Approximately 3 years.
|
|
Phase 3 - Duration of Response (DOR) per RECIST 1.1 by BICR.
Time Frame: Approximately 3 years.
|
DOR: For subjects who demonstrated CR or PR, DOR is defined as the time from first documented evidence of CR or PR until disease progression or death, whichever occurs first per RECIST 1.1 by BICR. |
Approximately 3 years.
|
|
Phase 3 - Clinical Benefit Rate (CBR) per RECIST 1.1 by BICR.
Time Frame: Approximately 3 years.
|
Clinical Benefit Rate: For subject who demonstrated CR + PR + SD>6 months per RECIST 1.1 by BICR. |
Approximately 3 years.
|
|
Phase 3 - ORR, per RECIST 1.1 by investigator's assessment.
Time Frame: Approximately 3 years.
|
ORR, per RECIST 1.1 as determined by investigator's assessment. |
Approximately 3 years.
|
|
Phase 3 - DOR, per RECIST 1.1 by investigator's assessment.
Time Frame: Approximately 3 years.
|
DOR, per RECIST 1.1 as determined by investigator's assessment. |
Approximately 3 years.
|
|
Phase 3 - PFS, per RECIST 1.1 by investigator's assessment.
Time Frame: Approximately 3 years.
|
PFS, per RECIST 1.1 as determined by investigator's assessment. |
Approximately 3 years.
|
|
Phase 3 - 14. Time to deterioration (TTD) in global health status measured by the EORTC QLQ C30 items for global health status and quality of life scale (item 29/30)
Time Frame: Approximately 3 years.
|
To evaluate TTD in global health status/quality of life in subjects treated with ficerafusp alfa in combination with pembrolizumab versus placebo plus pembrolizumab. TTD is defined as the time from Baseline to the first onset of a ≥10-point negative change (decrease) from Baseline in QoL using the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30 Item 30) score. Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. A higher value indicates a better level of function. |
Approximately 3 years.
|
|
Phase 3 - Time to deterioration (TTD) in pain measured by the EORTC HN 35 (items 31-34) pain domain.
Time Frame: Approximately 3 years.
|
To evaluate TTD in pain in subjects treated with ficerafusp alfa in combination with pembrolizumab versus placebo plus pembrolizumab. TTD defined as the time from first dose (baseline) to change in pain score by 10-point from baseline, using the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core Head and Neck Module (EORTC HN35). A higher score indicates a higher level of symptom burden. |
Approximately 3 years.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Bone Diseases
- Musculoskeletal Diseases
- Neoplasms by Site
- Neoplasms
- Genetic Diseases, Inborn
- Respiratory Tract Diseases
- Neoplasms by Histologic Type
- Neoplasms, Glandular and Epithelial
- Carcinoma
- Otorhinolaryngologic Diseases
- Carcinoma, Squamous Cell
- Osteochondrodysplasias
- Bone Diseases, Developmental
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Squamous Cell Carcinoma of Head and Neck
- Head and Neck Neoplasms
- Laryngeal Diseases
- Camurati-Engelmann Syndrome
- pembrolizumab
Other Study ID Numbers
Other Study ID Numbers
- BCA101X301
- 2024-519654-37-00 (Ctis)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.